PLASMA Chile: A prospective, multicenter observational cohort study of patients with heart failure and reduced left ventricular ejection fraction
In Chile, patients with HF with reduced LVEF receive pharmacological therapy consistent with international standards; however, they face access barriers to CIEDs, which are underutilized despite their benefits.
Authors
- Fernando Laņas (ORCID: https://orcid.org/0000-0003-3595-9759)
- Ricardo Pérez‐Cuevas (ORCID: https://orcid.org/0000-0002-5564-5821)
- Pablo López (ORCID: https://orcid.org/0000-0002-7368-2220)
- Rubén Aguayo
- Svetlana V. Doubova (ORCID: https://orcid.org/0000-0002-0521-7095)
- Hugo Verdejo (ORCID: https://orcid.org/0000-0003-0078-4792)
- Remigio Aguirre
- Álvaro Osornio-Vargas (ORCID: https://orcid.org/0000-0001-8287-7102)
- J. Riesgo
- Claudio Muratore
- Federico Levy
Institutions
- Pontificia Universidad Católica de Chile (CL)
- Mexican Social Security Institute (MX)
- Medtronic (Ireland) (IE)
- Secretaria de Salud (HN)
- Hospital Regional de Concepción (CL)
- Hospital San Juan de Dios (CL)
- Instituto para la Atención y Prevención de las Adicciones (MX)
- Hospital Dr. Gustavo Fricke (CL)
- Hospital Metropolitano (EC)
- Hospital Doctor Hernán Henríquez Aravena (CL)
Publication Details
- Journal
- Heart Rhythm O2
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1016/j.hroo.2025.09.015
- Primary Topic
- Cardiovascular Function and Risk Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Heart Association